Inside a plant in China producing the WHO-approved Sinovac Covid-19 vaccine | South China Morning Post
The WHO approval of Sinovac Biotech’s coronavirus vaccine for emergency use on June 1, 2021, will help ease the global vaccine shortage. Sinovac Biotech has already distributed more than 600 million doses of its CoronaVac vaccine to nearly 40 countries, as of May 31, 2021. It uses an inactivated virus to trigger a p…
Read at South China Morning PostOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.